Australia markets close in 20 minutes

Evoke Pharma, Inc. (EV00.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.6150-0.0100 (-1.60%)
At close: 08:23AM CET
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,301
2,509
1,618
23.02
Cost of revenue
332.939
370.394
328.118
86.712
Gross profit
3,968
2,138
1,290
-63.692
Operating expenses
Research development
186.554
300.789
590.476
6,555
Selling general and administrative
11,034
9,624
8,851
6,429
Total operating expenses
11,221
9,924
9,442
12,984
Operating income or loss
-7,253
-7,786
-8,152
-13,047
Interest expense
500
500
500.05
112.994
Total other income/expenses net
-
-
105.13
-
Income before tax
-7,608
-8,224
-8,538
-13,155
Income from continuing operations
-7,608
-8,224
-8,538
-13,155
Net income
-7,608
-8,224
-8,538
-13,155
Net income available to common shareholders
-7,608
-8,224
-8,538
-13,155
Basic EPS
-2.27
-2.62
-3.18
-6.24
Diluted EPS
-2.27
-2.62
-3.18
-6.24
Basic average shares
3,343
3,144
2,682
2,124
Diluted average shares
3,343
3,144
2,682
2,124